REV-MED's Breakthrough at Hospitalar 2025

REV-MED participated in “Hospitalar 2025,” an international medical equipment exhibition held in São Paulo, Brazil from May 20 to 23, making a strong impression in the Latin American market.

Hospitalar is the largest medical device exhibition in South America, and this year it attracted over 1200 companies and more than 100,000 healthcare professionals from around the world.

At the exhibition, REV-MED showcased TriCell and NovaStem, both of which apply advanced biological extraction technology using autologous blood and bone marrow. These innovations drew significant attention from local medical professionals and buyers.

Brazil is the largest medical device market in Latin America and ranks among the top 10 globally, with a market size reaching $4.7 billion as of 2015. The regenerative medicine sector in South America is experiencing rapid growth, and Brazil, in particular, is regarded as a key market in the region.

According to a global market research report, the regenerative medicine market in Latin America is expected to grow from $2.6 billion in 2024 to $8.1 billion by 2029. The PRP (Platelet-Rich Plasma) cell therapy market is also projected to expand from $9.06 billion in 2024 to $25 billion by 2032. PRP cell therapy involves extracting platelets from the patient's own blood and injecting them into the joint cavity. Due to the use of autologous blood, this method carries a low risk of immune rejection or side effects.

REV-MED has already proven its technological capabilities in the global market by obtaining stringent regulatory approvals, including those from Japan’s PMDA and China’s NMPA. In particular, the company has accelerated its entry into the Asian market through approval from Japan’s Ministry of Health, Labour and Welfare. Currently, REV-MED exports its products to over 30 countries, including those in Europe and the Middle East. Additionally, by publishing more than 20 SCI-level papers, the company has strengthened its academic presence and enhanced trust in its technology.

A REV-MED representative stated, “Through our participation in the Brazilian medical device exhibition, we have laid the groundwork for entering the South American market and will continue to strengthen our leading position in the global regenerative medicine field.” They added, “Moving forward, we will focus on expanding our global presence and delivering advanced medical solutions based on our proprietary technologies and innovative capabilities.”